Atlas Trials

A Phase 1 Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of AS-S603 in Healthy Participants

Clinical trial NCT06786676 · RECRUITING

Trial details

NCT number
NCT06786676
Sponsor
Amyloid Solution Inc
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2025-05-26
Primary completion
2026-12-31
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.